BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

EffRx 

601 Heritage Drive
Suite 208
Jupiter  Florida  33458  U.S.A.
Phone: 561-622-0321 Fax: 561-623-5509


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





 Company News
EffRx Signs Distribution Agreements For Binosto® In Italy, Spain And Portugal 2/4/2014 9:58:24 AM    More...
Ascendancy Healthcare Announces Distribution Partnership With EffRx 11/4/2013 10:07:13 AM    More...
EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for Polycystic Ovary Syndrome (PCOS) in Paediatric Populations 10/1/2013 10:50:19 AM    More...
EffRx Signs Distribution Agreement With Ahn-Gook Pharmaceuticals for Binosto® for Korea 6/3/2013 10:58:14 AM    More...
Mission Pharmacal Company and EffRx Bring New Osteoporosis Medication to the United States and Canada 4/18/2012 9:47:56 AM    More...
FDA Approves EffRx's BINOSTO®, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution 3/14/2012 9:34:24 AM    More...
EffRx Announces Issuance of US Patent Providing Further Protection to EX101, Effervescent Alendronate Weekly Dosing Form 7/11/2011 11:06:09 AM    More...
First EffRx NDA Accepted for Filing by the FDA 5/11/2011 8:23:22 AM    More...
EffRx Pharmaceuticals SA Announces Move from United States to Switzerland and Appointment of New Management and Board Members 1/11/2011 9:35:53 AM    More...
EffRx and Nycomed Announces First European Filing for Marketing Approval of Osteoporosis Drug Targeting Increased Convenience for Patients 9/21/2010 10:34:17 AM    More...
12

//-->